Curasight
Mindre end 1K følgere
Latest research
Latest analysis report
Released: 21.01.2025
ViserAlle indholdstyper
Curasight (One-pager): Extensive pipeline milestones in 2025
Participation in warrant exercise by Curasight management
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Dagens aktienyheder 10/12: Spar Nord, Embla Medical, Curasight
Curasight A/S announces outcome of warrant exercise
Curasight: SEB maintain valuation range midpoint at DKK 54 per share
Curasight: The last day of trading in warrants of series TO2 is on the 3[rd] of December 2024
Dagens aktienyheder 26/11: Asetek og Curasight
Curasight: Interview med CEO Ulrich Krasilnikoff og CSO Andreas Kjær efter aflagt 3. kvartalsregnskab
BioStock: Curasight CEO reflects on a Q3 with strong progress
Curasight – Opdatering på 3. kvartal 2024
Dagens aktienyheder 25/11: Curasight
Curasight and Curium sign global radioisotope supply agreement for uTREAT[®]
Dagens aktienyheder 21/11: Scandinavian Medical Solutions og Curasight
Curasight: Q3 report and exercise period in warrant TO2 starts
Curasight: The exercise period for warrants of series TO2 commences today
Curasight: Interim report Q3 2024
Dagens aktienyheder 20/11: Vestjysk Bank, Penneo A/S, Scandinavian Medical Solutions og Curasight
Curasight: The exercise price for warrants of series TO2 has been set to DKK 11.50 per new share
